RU2017137960A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017137960A3 RU2017137960A3 RU2017137960A RU2017137960A RU2017137960A3 RU 2017137960 A3 RU2017137960 A3 RU 2017137960A3 RU 2017137960 A RU2017137960 A RU 2017137960A RU 2017137960 A RU2017137960 A RU 2017137960A RU 2017137960 A3 RU2017137960 A3 RU 2017137960A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2015/001316 WO2016156912A1 (en) | 2015-04-01 | 2015-04-01 | Use of thia oxo compounds for lowering apo c3 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017137960A RU2017137960A (ru) | 2019-05-06 |
| RU2017137960A3 true RU2017137960A3 (https=) | 2019-05-06 |
| RU2705991C2 RU2705991C2 (ru) | 2019-11-13 |
Family
ID=53879725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017137960A RU2705991C2 (ru) | 2015-04-01 | 2015-04-01 | Применение тиаоксосоединений для уменьшения содержания аро с3 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180110747A1 (https=) |
| JP (1) | JP2018510206A (https=) |
| KR (1) | KR20180010181A (https=) |
| AU (1) | AU2015389862B2 (https=) |
| MX (1) | MX388141B (https=) |
| RU (1) | RU2705991C2 (https=) |
| WO (1) | WO2016156912A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017023164A2 (en) | 2015-04-28 | 2018-07-24 | Pronova Biopharma Norge As | and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof |
| HRP20241643T1 (hr) | 2017-12-06 | 2025-02-14 | Basf As | Derivati masnih kiselina za liječenje nealkoholnog steatohepatitisa |
| JP7508447B2 (ja) | 2018-05-23 | 2024-07-01 | ノースシー セラピューティクス ベスローテン フェンノートシャップ | 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸 |
| WO2022137125A1 (en) | 2020-12-22 | 2022-06-30 | Northsea Therapeutics B.V. | Combination therapies comprising oxygen-containing structurally enhanced fatty acids for treatment of non-alcoholic steatohepatitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG175401A1 (en) * | 2009-05-08 | 2011-12-29 | Pronova Biopharma Norge As | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| MY170076A (en) * | 2010-11-05 | 2019-07-03 | Pronova Biopharma Norge As | Methods of treatment using lipid compounds |
| HK1206248A1 (en) * | 2012-05-07 | 2016-01-08 | Omthera Pharmaceuticals Inc. | Compositions of statins and omega-3 fatty acids |
| WO2014132134A1 (en) * | 2013-02-28 | 2014-09-04 | Pronova Biopharma Norge As | A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same |
-
2015
- 2015-04-01 US US15/562,554 patent/US20180110747A1/en not_active Abandoned
- 2015-04-01 KR KR1020177031665A patent/KR20180010181A/ko not_active Ceased
- 2015-04-01 MX MX2017012641A patent/MX388141B/es unknown
- 2015-04-01 WO PCT/IB2015/001316 patent/WO2016156912A1/en not_active Ceased
- 2015-04-01 JP JP2017552093A patent/JP2018510206A/ja active Pending
- 2015-04-01 AU AU2015389862A patent/AU2015389862B2/en active Active
- 2015-04-01 RU RU2017137960A patent/RU2705991C2/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018510206A (ja) | 2018-04-12 |
| RU2705991C2 (ru) | 2019-11-13 |
| RU2017137960A (ru) | 2019-05-06 |
| US20180110747A1 (en) | 2018-04-26 |
| WO2016156912A1 (en) | 2016-10-06 |
| MX388141B (es) | 2025-03-19 |
| AU2015389862B2 (en) | 2021-04-15 |
| KR20180010181A (ko) | 2018-01-30 |
| MX2017012641A (es) | 2018-06-06 |
| AU2015389862A1 (en) | 2017-11-23 |